Suppr超能文献

晚期慢性肾脏病患者的亚临床甲状腺功能减退症:患病率及相关因素

Subclinical Hypothyroidism in Advanced Chronic Kidney Disease Patients: Prevalence and Associated Factors.

作者信息

Reque Santivañez Javier, Garcia Peris Beatriz, Panizo Gonzalez Nayara, Perez Alba Alejandro, D'Marco Luis, Collado Boira Eládio

机构信息

Hospital General Universitario de Castellón, Nephrology Department, Valencia, Spain.

Hospital Clínico Universitario de Valencia, INCLIVA, Nephrology Department, Valencia, Spain.

出版信息

J Thyroid Res. 2022 May 17;2022:1077553. doi: 10.1155/2022/1077553. eCollection 2022.

Abstract

INTRODUCTION

Renal function and thyroid metabolism are tightly related. However, evidence about subclinical hypothyroidism prevalence in patients with chronic kidney disease and its related factors is scarce.

OBJECTIVES

Our aim is to analyze subclinical hypothyroidism prevalence and its related factors in patients with advanced chronic kidney disease. . Nondialysis-dependent patients with chronic kidney disease at stages 3 to 5 were included. Other inclusion criteria were age above 18 years and clinical stability. Patients with diagnosed thyroid illnesses were excluded. Subclinical hypothyroidism was defined as thyroid stimulating hormone (TSH) > 5.3 mU/L, with free thyroxine 4 (FT4) between 0.54 and 1.24 ng/dl. Filiation data, comorbidities, and routine blood and urine test results were registered.

RESULTS

A total of 299 patients were included. Of them, 184 (61.5%) were men. The mean age was 71 ± 13 years old. The mean glomerular filtration rate (CKD-EPI) was 22 ± 9 ml/min/1.73 m. According to chronic kidney disease stages, global distribution of patients was as follows: Stage 3, 67 patients (22.4%); Stage 4, 155 patients (51.8%); and Stage 5, 77 patients (25.8%). We found subclinical hypothyroidism in 54 (18.1%) patients. According to chronic kidney disease stages, distribution of affected patients was as follows: Stage 3, 9 patients (13%); Stage 4, 25 patients (16.1%); and Stage 5, 20 patients (26%). Differences among stages were statistically significant. By univariate analysis, factors related with subclinical hypothyroidism were as follows: age RR 1.048 (95% CI 1.019-1.078; =0.001), hypertension RR 2.705 (95% CI 1.026-7.130; =0.04), glomerular filtration rate RR 0.962 (95% CI 0.929-0.996; =0.03), and proteinuria higher than 1 gram/day RR 2.387 (95% CI 1.303-4.374; =0.005). By multivariate analysis adjusted by age, hypertension, glomerular filtration rate, proteinuria, diabetes, and cardiovascular disease history, only age RR 1.016 (95% CI 1.009-1.028; =0.04) and glomerular filtration rate RR 0.963 (95% CI 0.930-0.997; =0.03) preserved their independent association with subclinical hypothyroidism.

CONCLUSIONS

Subclinical hypothyroidism prevalence in patients with chronic kidney disease is high and increases with renal disease severity. Factors independently related to subclinical hypothyroidism are age and glomerular filtration rate.

摘要

引言

肾功能与甲状腺代谢密切相关。然而,关于慢性肾脏病患者亚临床甲状腺功能减退症的患病率及其相关因素的证据却很匮乏。

目的

我们的目的是分析晚期慢性肾脏病患者亚临床甲状腺功能减退症的患病率及其相关因素。纳入3至5期非透析依赖的慢性肾脏病患者。其他纳入标准为年龄在18岁以上且临床状况稳定。排除已确诊甲状腺疾病的患者。亚临床甲状腺功能减退症的定义为促甲状腺激素(TSH)>5.3 mU/L,游离甲状腺素4(FT4)在0.54至1.24 ng/dl之间。记录家族史、合并症以及常规血液和尿液检查结果。

结果

共纳入299例患者。其中,184例(61.5%)为男性。平均年龄为71±13岁。平均肾小球滤过率(CKD-EPI)为22±9 ml/min/1.73 m²。根据慢性肾脏病分期,患者的总体分布如下:3期,67例(22.4%);4期,155例(51.8%);5期,77例(25.8%)。我们发现54例(18.1%)患者存在亚临床甲状腺功能减退症。根据慢性肾脏病分期,受影响患者的分布如下:3期,9例(13%);4期,25例(16.1%);5期,20例(26%)。各分期之间的差异具有统计学意义。单因素分析显示,与亚临床甲状腺功能减退症相关的因素如下:年龄RR 1.048(95%CI 1.019-1.078;P=0.001),高血压RR 2.705(95%CI 1.026-7.130;P=0.04),肾小球滤过率RR 0.962(95%CI 0.929-0.996;P=0.03),以及蛋白尿高于1克/天RR 2.387(95%CI 1.303-4.374;P=0.005)。在对年龄、高血压、肾小球滤过率、蛋白尿、糖尿病和心血管疾病史进行校正的多因素分析中,只有年龄RR 1.016(95%CI 1.009-1.028;P=0.04)和肾小球滤过率RR 0.963(95%CI 0.930-0.997;P=0.03)与亚临床甲状腺功能减退症保持独立关联。

结论

慢性肾脏病患者亚临床甲状腺功能减退症的患病率较高,且随肾脏疾病严重程度增加而升高。与亚临床甲状腺功能减退症独立相关的因素是年龄和肾小球滤过率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/151a/9130009/7add98543287/JTR2022-1077553.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验